# Oxarc, LLC – FDA Inspection, Jul 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/oxarc-llc/2848ec19-a366-4e01-8aa7-0f25407e3e25
Source feed: FDA_Inspections

> FDA inspection 1018413 of Oxarc, LLC, July 14, 2017. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1018413
- Company Name: Oxarc, LLC
- Inspection Date: 2017-07-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Officers

- [Marijo B. Kambere](https://www.keypedia.com/people/marijo-b-kambere/54e010f0-0d56-4b20-b5e2-112e372de58b)

Company: https://www.keypedia.com/companies/oxarc-llc/b5e38975-403e-4b23-80df-08d0ba1e8989

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c